A conversation at the frontier of digital health innovation, FDA regulations, and cognitive health
Digital Therapeutics for MCI and Alzheimer’s disease: A Regulatory Perspective (The Journal of Prevention of Alzheimer’s Disease): –This article is adapted […]
Learn more →
